Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | KIF11 | P52732 | 2/20 | 0.50 |
| ▸ | GABRP | O00591 | 2/20 | 0.49 |
| ▸ | GABRD | O14764 | 2/20 | 0.49 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.49 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.49 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.49 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.49 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.49 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.49 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.49 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.49 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.49 |
| ▸ | GABRE | P78334 | 2/20 | 0.49 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.49 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.49 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29440653 | 1.00 | AHR (1.00) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL21479869 | 0.90 | AHR (0.82) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL528428 | 0.83 | MEN1 (0.70) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL17523326 | 0.81 | AHR (0.67) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL21479976 | 0.80 | AHR (0.65) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL28118998 | 0.75 | MEN1 (0.60) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL27595286 | 0.75 | AHR (0.60) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL23875361 | 0.75 | MAPT (0.59) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL23502862 | 0.75 | MEN1 (0.59) | AHRMEN1MAPTKMT2AKIF11 | |
| SCHEMBL23875376 | 0.75 | MEN1 (0.59) | AHRMEN1MAPTKMT2AKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 724 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250345316-A1 | METHODS OF INCREASING LYMPHOCYTE TRAFFICKING TO THE COLON BY STIMULATING RETINOIC ACID RECEPTORS AND ARYL HYDROCARBON RECEPTORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-13 | — | — | US | claimed |
| US-12435117-B2 | Method for producing immune cells and use thereof | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2025-10-07 | — | — | US | claimed |
| US-20250223558-A1 | LARGE SCALE MANUFACTURING OF IPSC DERIVED HSC AND PROGENY | CELYNTRA THERAPEUTICS SA (BE) | 2025-07-10 | — | — | US | claimed |
| US-20250177503-A1 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-06-05 | — | — | US | claimed |
| US-20250115871-A1 | METHODS TO IMPROVE ENDURING HEMATOPOIETIC STEM CELL TRANSPLANTATION | TRAILHEAD BIOSYSTEMS INC. | 2025-04-10 | — | — | US | claimed |
| CN-119258221-B | Application of AhR agonist in preparation of medicine for treating radiation pneumonitis | 吉林大学 | 2025-04-04 | — | — | CN | claimed |
| EP-4504915-A1 | LARGE SCALE MANUFACTURING OF IPSC DERIVED HSC AND PROGENY | Celyntra Therapeutics SA (BE) | 2025-02-12 | — | — | EP | claimed |
| EP-4482511-A2 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS | The Regents of The University of Michigan (US) | 2025-01-01 | — | — | EP | claimed |
| WO-2024253957-A1 | TARGETING AUTOIMMUNITY-ASSOCIATED T CELLS THROUGH REGULATION OF TRANSCRIPTION FACTORS | NORTHWESTERN UNIVERSITY (US) | 2024-12-12 | — | — | WO | claimed |
| CN-119053336-A | Compositions and methods for treating autoimmune disorders | 密执安大学评议会 | 2024-11-29 | — | — | CN | claimed |
| US-20110262457-A1 | MODULATION OF THE IMMUNE RESPONSE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-10-27 | — | — | US | claimed |
| EP-2276833-A1 | MODULATION OF THE IMMUNE RESPONSE | The Brigham and Women's Hospital, Inc. (US) | 2011-01-26 | — | — | EP | claimed |
| US-20100324109-A1 | Composition for Topical Use | THESAN PHARMACEUTICALS, INC. | 2010-12-23 | — | — | US | claimed |
| US-7855310-B2 | AH receptor antagonists | SYMRISE GMBH & CO. KG (DE) | 2010-12-21 | — | — | US | claimed |
| EP-2237775-A1 | COMPOSITION FOR TOPICAL USE | Saurat, Jean Hilaire (CH) | 2010-10-13 | — | — | EP | claimed |
| EP-2224921-A2 | MODULATION OF THE IMMUNE RESPONSE | The Brigham and Women's Hospital, Inc. (US) | 2010-09-08 | — | — | EP | claimed |
| WO-2009117597-A1 | MODULATION OF THE IMMUNE RESPONSE | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2009-09-24 | — | — | WO | claimed |
| WO-2009093207-A1 | COMPOSITION FOR TOPICAL USE | SAURAT JEAN HILAIRE (CH) | 2009-07-30 | — | — | WO | claimed |
| EP-2082736-A1 | Pharmaceutical composition for local use | Saurat, Jean Hilaire (CH) | 2009-07-29 | — | — | EP | claimed |
| WO-2009067349-A2 | MODULATION OF THE IMMUNE RESPONSE | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2009-05-28 | — | — | WO | claimed |